MCK — MCKESSON CORP

NYSE · Consumer Discretionary · Distributors · CIK 927653 ·
Last close
$763.91
Market Cap
$89.44B
52W High
$891.23
52W Low
$722.88
ADV30
1,199,125
Next earnings
2026-08-05
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 96,295,000,000 4,044,000,000 2,248,000,000 1,682,000,000 82,323,000,000 3,975,000,000 83,157,000,000
Dec 2025 106,158,000,000 3,685,000,000 1,655,000,000 1,186,000,000 84,190,000,000 2,959,000,000 84,289,000,000
Sep 2025 103,150,000,000 3,542,000,000 1,468,000,000 1,110,000,000 84,160,000,000 4,004,000,000 84,738,000,000
Jun 2025 97,827,000,000 3,279,000,000 1,083,000,000 784,000,000 81,311,000,000 2,418,000,000 82,174,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$10,482,000,000
Investing CF
$-4,081,000,000
Financing CF
$-4,666,000,000
CapEx
$-838,000,000
Dividends Paid
$-371,000,000
Buybacks
$-2,379,000,000
EPS Diluted TTM
$34.77
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$20,710,000,000
Inventory
$27,067,000,000
Receivables
$28,213,000,000
ST Investments
EBIT TTM
$5,822,000,000
Pretax Income TTM
$5,591,000,000
Interest Exp TTM
$231,000,000
Analysts
15

Yahoo Snapshot (yfinance, live)

Total Revenue
$403,430,014,976
EBITDA
$6,883,999,744
Free Cash Flow
$5,657,625,088
Enterprise Value
$97,974,075,392
Total Cash
$3,975,000,064
Total Debt
$8,785,999,872
Shares Out
117,077,745
Trailing EPS
$38.35
Book Value
$-18.10
ROE
ROA
5.0%
Div Yield
0.43%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Mar 2026 403,430,000,000 6,454,000,000 4,762,000,000 82,323,000,000 83,157,000,000 6,155,000,000
Mar 2025 359,051,000,000 4,816,000,000 3,295,000,000 75,140,000,000 76,834,000,000 6,085,000,000
Mar 2024 308,951,000,000 4,171,000,000 3,002,000,000 67,443,000,000 69,042,000,000 4,314,000,000
Mar 2023 276,711,000,000 4,582,000,000 3,560,000,000 62,320,000,000 63,810,000,000 5,159,000,000

TTM Snapshot

Revenues TTM
$315,296,000,000
NetIncome TTM
$2,540,000,000
OpCashFlow TTM
$0
Assets (Latest)
$75,140,000,000
Forward EPS
$50.34

Max Pain — expiry 2027-01-15

max pain strike: $740.00 · spot: $774.00 · call oi: 2,184 · put oi: 1,430
Expected Move to 2027-01-15: ±$140.30 (18.13%) — implied range $633.70$914.30 · ATM straddle on $780.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
GWW W.W. GRAINGER, INC. $62.34B $1320.48
TEL TE Connectivity plc $59.27B $203.05
COR Cencora, Inc. $54.69B $281.10
CAH CARDINAL HEALTH INC $53.61B $228.91
FERG Ferguson Enterprises Inc. /DE/ $45.39B $234.05

News headlines (Yahoo Finance, 1h cache)

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
2026-06-24 13:00 · Yahoo
McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date
2026-06-24 12:00 · Yahoo
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
2026-06-23 23:53 · Yahoo
McKesson Selects Moore, Oklahoma for a State-of-the-Art Regional Distribution Center Positions Cleveland County as a National Healthcare Supply Chain Hub
2026-06-23 19:41 · Yahoo
McKesson ideaShare 2026 Fuels Momentum for Independent Pharmacies
2026-06-23 12:00 · Yahoo
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
2026-06-19 17:10 · Yahoo
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
2026-06-19 12:36 · Yahoo
McKesson (MCK) Stock Sinks As Market Gains: Here's Why
2026-06-18 21:50 · Yahoo
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
2026-06-18 16:49 · Yahoo
Is McKesson’s New US$2.25 Billion Term Loan Reshaping the Investment Case for MCK?
2026-06-15 07:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.